HOME >> MEDICINE >> NEWS
OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients

PORTLAND, Ore. -- Data from an ongoing study designed to explore the biologic and clinical activity of cancer immunotherapy sipuleucel-T, or Provenge, in patients with early stage recurrent prostate cancer who have a rising serum prostate specific antigen (PSA) level, but who have not yet developed metastatic disease will be presented by Oregon Health & Science University Cancer Institute researchers.

The study showed that sipuleucel-T did not significantly delay the time it took for a patient's PSA to reach a value of 3 ng/ml, the primary endpoint of the study, but it did show a prolongation in prostate-specific antigen doubling time (PSADT). In addition, there was a trend observed in slowing the time to metastatic disease for patients who received sipuleucel-T compared with those who received placebo, but this early trend did not reach statistical significance. The findings will be presented Saturday, June 2, at 8 a.m. (CDT) at the 43rd Annual Meeting of the American Society of Clinical Oncologists (ASCO) in Chicago.

"While there was no delay in the time to PSA recurrence, we did observe a slowing in the rate of rise of serum PSA in exploratory analyses. Additional follow-up is needed to determine if this effect on PSA will translate into patient benefits," said Tomasz Beer, M.D., lead investigator, director of the Prostate Cancer Research program at the OHSU Cancer Institute; and associate professor of medicine, (hematology/medical oncology) OHSU School of Medicine.

The ongoing trial, known as P-11, is a double-blind, multi-center, randomized, placebo-controlled study involving 176 men, all of whom had prostatectomies and then had recurrent cancer as detected by a rise in the serum tumor marker, PSA. After three months of hormone therapy, 117 men received sipuleucel-T and 59 received placebo.

Sipuleucel-T was found to have a favorable safety profile. The most common side effects seen more commonly in sipuleucel-T-t
'"/>

Contact: Christine Decker
deckerch@ohsu.edu
503-494-8231
Oregon Health & Science University
2-Jun-2007


Page: 1 2 3

Related medicine news :

1. American Cancer Society to hold third annual Virtual Relay For Life in Second Life
2. Cancer research summaries
3. Cancer on the agenda of the Portuguese EU Council Presidency
4. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research
5. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
6. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
7. Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer
8. Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
9. Margaret Foti receives AACR Award for Leadership and Extraordinary Achievements in Cancer Research
10. Cancer-fighting foods, supplements explored in day-long symposium, March 25
11. Cancer vaccine innovator honored with prestigious Florey Medal

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... , ... Yes, the Millennials love their Bluetooth earbuds and Alexa smart speakers. ... new tech is also finding a home in senior living communities. , The ... variety of organizations that work with older adults about their adoption of technology over ...
(Date:1/14/2019)... ... January 14, 2019 , ... Trees can be overweight too! ... should have trees pruned, and winter is a great time to clean things up ... can lead to serious damage, especially during windy or icy storms. The crown of ...
(Date:1/13/2019)... ... January 12, 2019 , ... On December 13th, The Pennsylvania ... hosted a continuing education (CEU) event entitled, Can You Hear Me Now? Creating ... a series of talks to help develop and cultivate the relationship between mentors ...
(Date:1/11/2019)... ... January 11, 2019 , ... Ms. Barrios, a first generation ... alleges that Andrews and others engaged in a systematic pattern of discrimination against ... employees by race and by the color of their skin, and directed Ms. ...
(Date:1/10/2019)... ... January 10, 2019 , ... Net-Translators, an industry-leading provider of ... regulatory consulting company that serves the medical industry. The companies naturally complement each ... medical device and healthcare industries. Based in France, they join Net-Translators’ program of ...
Breaking Medicine News(10 mins):
(Date:1/15/2019)... ... January 15, 2019 , ... ... locations for the 2019 Wound Certification Prep Course (WCPC), the leading comprehensive wound ... specialized knowledge in wound management, WCPC will be expanding its course to 12 ...
(Date:1/14/2019)... , ... January 14, 2019 , ... ... of grants, totaling $665,400, to 16 U.S.-based 501(c)(3) nonprofits that align with its ... all, and aid for those affected by natural disasters. Located in Arizona, California, ...
(Date:1/14/2019)... ... January 14, 2019 , ... Dexter foot and ankle podiatry has been serving the ... all your foot and ankle needs! We can help take care of you whether it ... of the foot pain or even any heel or ankle problems. We can help ...
Breaking Medicine Technology:
Cached News: